Evidence map›Paper›PMID 30650105›Full record

ArticlePLoS neglected tropical diseases2019

Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds.

Marc P Hübner, Alexandra Ehrens, Marianne Koschel, Bettina Dubben, Franziska Lenz, Stefan J Frohberger, Sabine Specht, Ludo Quirynen, Sophie Lachau-Durand, Fetene Tekle and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Combinations of the azaquinazoline anti-Frontiers in microbiology · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. In vivo imaging of transgenic Brugia malayi.PLoS neglected tropical diseases · 2020
    Article
  15. Article
  16. Article
  17. Mouse models of Loa loa.Nature communications · 2019
    Article
  18. Article
  19. Flubendazole as a macrofilaricide: History and background.PLoS neglected tropical diseases · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Marc P HübnerInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.ORCID 0000-0001-8885-418X
Alexandra EhrensInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Marianne KoschelInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Bettina DubbenInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Franziska LenzInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Stefan J FrohbergerInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
Sabine SpechtInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.ORCID 0000-0002-5351-5812
Ludo QuirynenJanssen R&D, Janssen Pharmaceutica, Beerse, Belgium.ORCID 0000-0002-2167-9249
Sophie Lachau-DurandJanssen R&D, Janssen Pharmaceutica, Beerse, Belgium.
Fetene TekleJanssen R&D, Janssen Pharmaceutica, Beerse, Belgium.
Benny BaetenJanssen R&D, Janssen Pharmaceutica, Beerse, Belgium.ORCID 0000-0001-9790-4142
Marc EngelenJanssen R&D, Janssen Pharmaceutica, Beerse, Belgium.ORCID 0000-0001-9604-5104
Charles D MackenzieNeglected Tropical Disease Support Center, Task Force for Global Health, Atlanta, GA, United States of America.ORCID 0000-0002-4939-6996
Achim HoeraufInstitute for Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.
University Hospital Bonn · DEJanssen (Belgium) · BEDrugs for Neglected Diseases Initiative · CHThe Task Force for Global Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flubendazole (FBZ) is highly efficacious against filarial nematodes after parenteral administration and presents a promising macrofilaricidal drug candidate for the elimination of onchocerciasis and other filariae. In the present study the efficacy of a newly developed bioavailable amorphous solid dispersion (ASD) oral formulation of FBZ was investigated in the Litomosoides sigmodontis jird model. FBZ was administered to chronically infected, microfilariae-positive jirds by single (40mg/kg), repeated (2, 6 or 15mg/kg for 5 or 10 days) oral (OR) doses or single subcutaneous (SC) injections (2 or 10mg/kg). Jirds treated with 5 SC injections at 10mg/kg served as positive controls, with untreated animals used as negative controls. After OR doses, FBZ is rapidly absorbed and cleared and the exposures increased dose proportionally. SC administered FBZ was slowly released from the injection site and plasma levels remained constant up to necropsy eight weeks after treatment end. Increasing single SC doses caused less than dose-proportional exposures. At necropsy, all animals receiving 1x or 5x 10mg/kg SC FBZ had cleared all adult worms and the 1x 2mg/kg SC treatment had reduced the adult worm burden by 98%. 10x 15mg/kg OR FBZ reduced the adult worm burden by 95%, whereas 1x 40mg/kg and 5x 15mg/kg OR reduced the worm burden by 85 and 84%, respectively. Microfilaremia was completely cleared at necropsy in all animals of the SC treatment regimens, while all oral FBZ treatment regimens reduced the microfilaremia by >90% in a dose and duration dependent manner. In accordance, embryograms from female worms revealed a FBZ dose and duration dependent inhibition of embryogenesis. Histological analysis of the remaining female adult worms showed that FBZ had damaged the body wall, intestine and most prominently the uterus and uterine content. Results of this study demonstrate that single and repeated SC injections and repeated oral administrations of FBZ have an excellent macrofilaricidal effect.

Indexed as

Administration, OralAnimalsDisease Models, AnimalEmbryonic DevelopmentFemaleFilariasisFilaricidesFilarioideaGerbillinaeMebendazoleParasite LoadFilaricidesflubendazoleMebendazole

Identifiers

PMID30650105
PMCPMC6334906
OpenAlexW2909279870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.